DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 01 · Volume 46 · Januar 2013 DOI: 10.1055/s-002-24306

AGNP News

  • I

    AGNP-Preis für Forschung in der Psychopharmakologie

    • Original Paper

  • 1
    von Wilmsdorff, M.; Bouvier, M.-L.; Henning, U.; Schmitt, A.; Schneider-Axmann, T.; Gaebel, W.:

    The Sex-Dependent Impact of Chronic Clozapine and Haloperidol Treatment on Characteristics of the Metabolic Syndrome in a Rat Model

  • 10
    Benninghoff, J.; Grunze, H.; Schindler, C.; Genius, J.; Schloesser, R. J.; van der Ven, A.; Dehning, S.; Wiltfang, J.; Möller, H.-J.; Rujescu, D.:

    Ziprasidone – Not Haloperidol – Induces more de-novo Neurogenesis of Adult Neural Stem Cells Derived from Murine Hippocampus

  • 16
    Laux, G.; Friede, M.; Müller, W. E.:

    Treatment of Comorbid Anxiety and Depression with Escitalopram: Results of a Post-Marketing Surveillance Study

  • 23
    Bliznak, L.; Berg, R.; Häge, A.; Dittmann, R. W.:

    High Rate of Non-Eligibility: Methodological Factors Impacting on Recruitment for a Multicentre, Double-Blind Study of Paediatric Patients with Major Depressive Disorder

  • 29
    Hochstrasser, T.; Ehrlich, D.; Sperner-Unterweger, B.; Humpel, C.:

    Antidepressants and Anti-Inflammatory Drugs Differentially Reduce the Release of NGF and BDNF from Rat Platelets

    • Letter

  • 35
    Bonnet, U.:

    Chronic Cannabis Abuse, Delta-9-tetrahydrocannabinol and Thyroid Function

  • 36
    Chapelle, C.; Quenet, S.; Delavenne, X.; Lacut, K.; Mismetti, P.; Laporte, S.; Beyens, M. N.:

    Antipsychotics: A Real or Confounding Risk Factor for Venous Thromboembolism?

  • 37
    Delić, M.; Pregelj, P.:

    Delirium during i. v. Citalopram Treatment: A Case Report

  • 39
    Gahr, M.; Kölle, M. A.; Freudenmann, R. W.; Schönfeldt-Lecuona, C.:

    Aseptic Gingivitis Related to Quetiapine Hemifumarate